Mass Balance Study to Investigate the Absorption, Metabolism and Excretion of [14C]-EYP001a After a Single Oral Dose
Clinical trial NCT04037618 · COMPLETED
Trial details
- NCT number
- NCT04037618
- Sponsor
- Enyo Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-24
- Primary completion
- 2019-07-27
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.